Coronary physiology: FFR and beyond
<p class="moderator speaker-name">Anchorperson: <span classs="personname">Niels Van Royen</span></p><p class="moderator speaker-name">Spokesperson: <span classs="personname">Rasha Al-Lamee</span></p><p class="moderator speaker-name">Discussants: <span classs="personname">Yolande Appelman, Thomas Engstrom, Hitoshi Matsuo, Ariel Roguin</span></p>
<div class="intervention"><div class="interventionTitle">A randomised trial of coronary function testing-guided treatment versus standard care in ANOCA</div><p class="speaker-intervention-name-img">Tim Van De Hoef</p></div><div class="intervention"><div class="interventionTitle">Discussion and audience interaction</div></div><div class="intervention"><div class="interventionTitle">Murray-law based quantitative flow ratio and graft patency after coronary artery bypass grafting</div><p class="speaker-intervention-name-img">Ho Young Hwang</p></div><div class="intervention"><div class="interventionTitle">Discussion and audience interaction</div></div><div class="intervention"><div class="interventionTitle">Impact of coronary microvascular dysfunction on patient-reported outcomes in patients undergoing PCI</div><p class="speaker-intervention-name-img">Frédéric Bouisset</p></div><div class="intervention"><div class="interventionTitle">Discussion and audience interaction</div></div><div class="intervention"><div class="interventionTitle">Absolute coronary flow and microvascular resistance changes after percutaneous coronary intervention</div><p class="speaker-intervention-name-img">Federico Marin</p></div><div class="intervention"><div class="interventionTitle">Discussion and audience interaction</div></div><div class="intervention"><div class="interventionTitle">Prognostic value of microvascular function in Takotsubo syndrome: pooled analysis of IPD</div><p class="speaker-intervention-name-img">Rob Eerdekens</p></div><div class="intervention"><div class="interventionTitle">Discussion and audience interaction</div></div>
